Promising Epigenetic Biomarkers for the Early Detection of Colorectal Cancer: A Systematic Review.
BMP3
CTCF
NDRG4
SDC2
SEPT9
biomarkers
colorectal cancer
early detection
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
02 Oct 2021
02 Oct 2021
Historique:
received:
01
08
2021
revised:
22
09
2021
accepted:
29
09
2021
entrez:
13
10
2021
pubmed:
14
10
2021
medline:
14
10
2021
Statut:
epublish
Résumé
In CRC, screening compliance is decreased due to the experienced discomfort associated with colonoscopy, although this method is the gold standard in terms of sensitivity and specificity. Promoter DNA methylation (hypomethylation or hypermethylation) has been linked to all CRC stages. Study objectives: to systematically review the current knowledge on approved biomarkers, reveal new potential ones, and inspect tactics that can improve performance. This research was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines; the risk of bias was evaluated using the revised Quality Assessment of Diagnostic Accuracy Studies criteria (QUADAS-2). The Web of Science
Identifiants
pubmed: 34638449
pii: cancers13194965
doi: 10.3390/cancers13194965
pmc: PMC8508438
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Sci Rep. 2020 Dec 17;10(1):22127
pubmed: 33335196
Genome Biol. 2014 Feb 03;15(2):R24
pubmed: 24490752
EBioMedicine. 2016 Feb 08;5:68-73
pubmed: 27077113
Gastroenterology. 2015 Oct;149(5):1204-1225.e12
pubmed: 26216839
Mol Oncol. 2021 Oct;15(10):2702-2714
pubmed: 33694305
Cancer Med. 2019 Sep;8(12):5619-5628
pubmed: 31407497
Clin Epigenetics. 2020 May 12;12(1):67
pubmed: 32398064
Sci Rep. 2020 Feb 18;10(1):2813
pubmed: 32071364
Gastroenterology. 2020 Mar;158(4):947-957.e4
pubmed: 31622624
Diagnostics (Basel). 2020 Jun 28;10(7):
pubmed: 32605302
Clin Epigenetics. 2020 Apr 21;12(1):56
pubmed: 32317010
Ann Clin Biochem. 2018 Jan;55(1):59-68
pubmed: 28081635
J Natl Cancer Inst. 2007 Oct 3;99(19):1462-70
pubmed: 17895475
Cancer. 2020 Apr 1;126(7):1460-1469
pubmed: 31909823
Ann Gastroenterol. 2017;30(6):613-621
pubmed: 29118555
BMC Cancer. 2019 May 14;19(1):450
pubmed: 31088406
Dis Markers. 2019 Apr 4;2019:5232780
pubmed: 31089394
Oncol Lett. 2020 Aug;20(2):1193-1200
pubmed: 32724359
J Cancer. 2019 Aug 28;10(21):5264-5271
pubmed: 31602277
J Cancer. 2021 Apr 30;12(12):3678-3685
pubmed: 33995643
Front Oncol. 2021 Feb 25;11:643136
pubmed: 33718241
Eur J Surg Oncol. 2020 Mar;46(3):316-320
pubmed: 31761509
JNCI Cancer Spectr. 2020 Nov 16;5(1):pkaa109
pubmed: 33442664
World J Gastrointest Oncol. 2010 Mar 15;2(3):151-8
pubmed: 21160823
Cancers (Basel). 2021 Apr 22;13(9):
pubmed: 33922024
Int J Mol Sci. 2020 May 11;21(9):
pubmed: 32403316
Front Oncol. 2019 May 21;9:394
pubmed: 31165042
Pathol Oncol Res. 2020 Apr;26(2):1165-1173
pubmed: 31183614
Am J Gastroenterol. 2019 Dec;114(12):1909-1918
pubmed: 31764091
J Mol Diagn. 2013 Jul;15(4):498-507
pubmed: 23747112
Front Oncol. 2020 Nov 27;10:544330
pubmed: 33330022
World J Gastrointest Oncol. 2020 Jun 15;12(6):619-631
pubmed: 32699577
Mol Diagn Ther. 2017 Apr;21(2):225-232
pubmed: 28155091
Oncotarget. 2018 Apr 20;9(30):21411-21428
pubmed: 29765549
Cancer Sci. 2020 Dec;111(12):4558-4566
pubmed: 32970347
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Front Genet. 2020 Apr 16;11:324
pubmed: 32373158
Front Oncol. 2021 Jan 29;10:621295
pubmed: 33585248
Front Genet. 2020 Jun 18;11:643
pubmed: 32625237
Clin Epigenetics. 2017 Dec 4;9:126
pubmed: 29225717
Epigenomics. 2020 Jan;12(1):37-52
pubmed: 31762318
Intest Res. 2018 Jul;16(3):327-337
pubmed: 30090031
J Cancer. 2021 Jan 1;12(2):335-342
pubmed: 33391430
Clin Epigenetics. 2021 Apr 15;13(1):80
pubmed: 33858496
Mol Cell. 2013 Jan 24;49(2):359-367
pubmed: 23177740
Oncol Lett. 2018 May;15(5):7675-7680
pubmed: 29725466
Ann Intern Med. 2011 Oct 18;155(8):529-36
pubmed: 22007046
Oncotarget. 2018 Mar 30;9(24):16974-16987
pubmed: 29682198
J Transl Med. 2018 Feb 27;16(1):45
pubmed: 29486770
Saudi J Biol Sci. 2018 Sep;25(6):1220-1226
pubmed: 30174526
Front Oncol. 2021 Apr 22;11:647066
pubmed: 33968748
Clin Epigenetics. 2019 Nov 14;11(1):158
pubmed: 31727158
Middle East J Dig Dis. 2017 Jul;9(3):158-163
pubmed: 28894518
Int J Mol Sci. 2020 Dec 24;22(1):
pubmed: 33374459
Clin Epigenetics. 2019 Mar 7;11(1):41
pubmed: 30846004
Front Oncol. 2018 Jul 02;8:247
pubmed: 30013949
Clin Interv Aging. 2016 Jul 19;11:967-76
pubmed: 27486317
Clin Transl Gastroenterol. 2020 Jun;11(6):e00176
pubmed: 32467409
Endocr Connect. 2019 Jul;8(7):979-987
pubmed: 31176300
Cancer Cell. 2019 Feb 11;35(2):315-328.e6
pubmed: 30753828
Int J Biol Markers. 2019 Mar;34(1):54-59
pubmed: 30852954
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
Front Genet. 2019 Jun 28;10:621
pubmed: 31316555
Gut Liver. 2018 Sep 15;12(5):479-480
pubmed: 30205668
Cancer Med. 2019 May;8(5):2133-2145
pubmed: 30993897
Gut Liver. 2018 Sep 15;12(5):508-515
pubmed: 29730903
Int J Mol Sci. 2020 Dec 28;22(1):
pubmed: 33379143
Dis Markers. 2018 Apr 23;2018:6437104
pubmed: 29849824
FEBS Open Bio. 2017 Dec 16;8(2):168-176
pubmed: 29435407
Clin Epigenetics. 2019 Mar 15;11(1):51
pubmed: 30876480
Tumour Biol. 2013 Oct;34(5):2469-76
pubmed: 23832537
Clin Epigenetics. 2021 Apr 23;13(1):90
pubmed: 33892797
Cancer Cell Int. 2020 Sep 1;20:426
pubmed: 32905102
Cancers (Basel). 2021 Apr 10;13(8):
pubmed: 33920293
Oncotarget. 2017 Feb 14;8(7):11906-11916
pubmed: 28060757
Oncotarget. 2017 Dec 11;8(69):114183-114194
pubmed: 29371978
Epigenomics. 2020 Oct;12(19):1677-1688
pubmed: 33078631
Nat Rev Dis Primers. 2015 Nov 05;1:15065
pubmed: 27189416
Sci Rep. 2019 Jul 17;9(1):10326
pubmed: 31316143
World J Gastroenterol. 2019 May 7;25(17):2099-2109
pubmed: 31114136
BMC Cancer. 2018 Oct 22;18(1):1023
pubmed: 30348132
Clin Epigenetics. 2021 Feb 3;13(1):26
pubmed: 33536049
Arch Med Sci. 2017 Oct;13(6):1281-1294
pubmed: 29181058
J Exp Clin Cancer Res. 2019 Oct 28;38(1):428
pubmed: 31665064
Mol Oncol. 2021 Jan;15(1):138-150
pubmed: 33107199
Clin Epigenetics. 2020 Jan 3;12(1):5
pubmed: 31900199
Int J Mol Sci. 2020 Jun 24;21(12):
pubmed: 32599859
Acta Biomed. 2018 Dec 17;89(9-S):97-101
pubmed: 30561401
EMBO Rep. 2021 Jun 4;22(6):e51913
pubmed: 33890711
World J Gastroenterol. 2018 Nov 28;24(44):5013-5024
pubmed: 30510376
Int J Mol Sci. 2020 Oct 07;21(19):
pubmed: 33036415
Cancer Manag Res. 2021 Apr 30;13:3601-3617
pubmed: 33958894
Biosci Rep. 2021 Jan 29;41(1):
pubmed: 33393623
Clin Epigenetics. 2017 Mar 3;9:24
pubmed: 28270869
PLoS One. 2016 Nov 29;11(11):e0163333
pubmed: 27898666
Cancer Epidemiol Biomarkers Prev. 2017 Sep;26(9):1411-1419
pubmed: 28619831
PLoS One. 2017 Jul 10;12(7):e0180809
pubmed: 28700744
J Clin Med. 2021 Jun 18;10(12):
pubmed: 34207031
Cancers (Basel). 2019 Feb 19;11(2):
pubmed: 30791468
Cancer Manag Res. 2019 Mar 27;11:2457-2470
pubmed: 30988641
Epigenetics. 2017 Sep;12(9):751-763
pubmed: 28753106
Clin Chem. 2019 Jul;65(7):916-926
pubmed: 31010820
Clin Epigenetics. 2020 Oct 30;12(1):162
pubmed: 33126908
Genome Biol. 2013;14(10):R115
pubmed: 24138928
Int J Genomics. 2021 Apr 21;2021:6613987
pubmed: 33977101
J Gen Physiol. 2019 Oct 7;151(10):1173-1189
pubmed: 31427379
Clin Epigenetics. 2018 May 29;10:70
pubmed: 29854011
Clin Epigenetics. 2020 Nov 30;12(1):184
pubmed: 33256852
J Cancer. 2021 Mar 5;12(9):2665-2672
pubmed: 33854626
Neurogastroenterol Motil. 2017 Sep;29(9):
pubmed: 28524415
Eur J Cancer Prev. 2021 Mar 1;30(2):127-131
pubmed: 32516173
Bioengineered. 2017 Sep 3;8(5):555-564
pubmed: 28140749
Front Genet. 2019 Sep 19;10:887
pubmed: 31608117
Br J Cancer. 2021 Jan;124(2):345-358
pubmed: 32968207
BMC Cancer. 2018 Nov 6;18(1):1068
pubmed: 30400781
Int J Cancer. 2018 Aug 15;143(4):907-920
pubmed: 29542109